These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11299436)

  • 1. [Central nervous system tuberculosis in children: 2. Treatment and outcome].
    Gusmão Filho FA; Marques-Dias MJ; Marques HH; Ramos SR
    Arq Neuropsiquiatr; 2001 Mar; 59(1):77-82. PubMed ID: 11299436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity.
    McNeill L; Allen M; Estrada C; Cook P
    Chest; 2003 Jan; 123(1):102-6. PubMed ID: 12527609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic enzyme abnormalities in children on triple therapy for tuberculosis.
    Corrigan D; Paton J
    Pediatr Pulmonol; 1999 Jan; 27(1):37-42. PubMed ID: 10023790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of and risk factors related to hepatotoxicity during tuberculosis treatment.
    Babalık A; Arda H; Bakırcı N; Ağca S; Oruç K; Kızıltaş S; Cetintaş G; Calışır HC
    Tuberk Toraks; 2012; 60(2):136-44. PubMed ID: 22779934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment.
    van Hest R; Baars H; Kik S; van Gerven P; Trompenaars MC; Kalisvaart N; Keizer S; Borgdorff M; Mensen M; Cobelens F
    Clin Infect Dis; 2004 Aug; 39(4):488-96. PubMed ID: 15356811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
    Gordin F; Chaisson RE; Matts JP; Miller C; de Lourdes Garcia M; Hafner R; Valdespino JL; Coberly J; Schechter M; Klukowicz AJ; Barry MA; O'Brien RJ
    JAMA; 2000 Mar; 283(11):1445-50. PubMed ID: 10732934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
    Schechter M; Zajdenverg R; Falco G; Barnes GL; Faulhaber JC; Coberly JS; Moore RD; Chaisson RE
    Am J Respir Crit Care Med; 2006 Apr; 173(8):922-6. PubMed ID: 16474028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central nervous system tuberculosis in adult patients].
    Lakatos B; Prinz G; Sárvári C; Kamotsay K; Molnár P; Abrahám A; Budai J
    Orv Hetil; 2011 Apr; 152(15):588-96. PubMed ID: 21436023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
    Iukhimenko NV
    Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide.
    Lin HS; Cheng CW; Lin MS; Chou YL; Chang PJ; Lin JC; Ye JJ
    Clin Interv Aging; 2016; 11():299-306. PubMed ID: 27042029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Woman With Confusion and Blurred Vision.
    Neoh PF; Tai ELM; Ahmad Tajudin LS
    JAMA Ophthalmol; 2018 May; 136(5):585-586. PubMed ID: 29450475
    [No Abstract]   [Full Text] [Related]  

  • 12. Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.
    Duarte R; Carvalho A; Correia A
    Public Health; 2012 Sep; 126(9):760-2. PubMed ID: 22633080
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.
    Villarino ME; Scott NA; Weis SE; Weiner M; Conde MB; Jones B; Nachman S; Oliveira R; Moro RN; Shang N; Goldberg SV; Sterling TR; ;
    JAMA Pediatr; 2015 Mar; 169(3):247-55. PubMed ID: 25580725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.
    Sharma SK; Singla R; Sarda P; Mohan A; Makharia G; Jayaswal A; Sreenivas V; Singh S
    Clin Infect Dis; 2010 Mar; 50(6):833-9. PubMed ID: 20156055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular tuberculosis in acquired immunodeficiency syndrome.
    Babu RB; Sudharshan S; Kumarasamy N; Therese L; Biswas J
    Am J Ophthalmol; 2006 Sep; 142(3):413-8. PubMed ID: 16935585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of chemotherapy of intrathoracic tuberculosis in children: late follow-up data].
    Iukhimenko NV
    Probl Tuberk; 2001; (5):19-22. PubMed ID: 11588952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediastina Tuberculosis mass in a three-month-old boy.
    Boussetta K; Tinsa F; Ghaffari H; Brini I; Aloui N; Jaubert F; Bousnina S
    Tunis Med; 2010 Aug; 88(8):602-4. PubMed ID: 20711969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of tuberculosis.
    Pinsker KL; Koerner SK
    Am J Hosp Pharm; 1976 Mar; 33(3):275-83. PubMed ID: 769544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):327-45. PubMed ID: 8000420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.